Carlo Lovati

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease

Daniela Galimberti, Chiara Fenoglio, Carlo Lovati et al. · Neurobiology of Aging · 2005 · 208 citations

Life Sciences, Neurology, Neuroscience +16

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli et al. · The Journal of Headache and Pain · 2021 · 150 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Plasma levels of beta-amyloid (1–42) in Alzheimer's disease and mild cognitive impairment

Marzia Pesaresi, Carlo Lovati, Pierluigi Bertora et al. · Neurobiology of Aging · 2006 · 111 citations

Life Sciences, Neurology, Neuroscience +14

MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels

Chiara Fenoglio, Daniela Galimberti, Carlo Lovati et al. · Neurobiology of Aging · 2004 · 90 citations

Life Sciences, Genetics, Neurology +15

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study

Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli et al. · European Journal of Neurology · 2021 · 76 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17